Why Novo Nordisk A/S (NVO) Stock Fell 2.2% on November 17, 2026
-2.16%$40.70November 17, 2026 · S&P 500 -1.01%
The short answer
Novo Nordisk A/S (NVO) is down 2.2% in the November 17, 2026 session, trading at 40.70. This decline is larger than the S&P 500 ETF (SPY), which is down 1.0% in the same session, indicating that the move is mostly specific to NVO or its industry. Recently, Seeking Alpha published a headline stating, "Novo Nordisk: The Thesis Is Working, The Stock Just Hasn't Noticed Yet," which may suggest reasons for the stock's underperformance. However, there is no single clear catalyst in the news directly explaining today's stock movement.
The news behind it
Novo Nordisk: The Thesis Is Working, The Stock Just Hasn't Noticed Yet · SeekingAlpha · Nov 17
Before you buy or sell
Get a second opinion on NVO
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when NVO moves
Price, RSI and volume alerts by email or push. Free plan →
Full market recap for November 17, 2026 · What's moving NVO today
Written from that session's quote and the headlines listed above. Educational, not financial advice.